| Product Code: ETC11479855 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cancer Therapeutics Biotherapeutics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cancer Therapeutics Biotherapeutics Market - Industry Life Cycle |
3.4 Israel Cancer Therapeutics Biotherapeutics Market - Porter's Five Forces |
3.5 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume Share, By Mechanism, 2021 & 2031F |
4 Israel Cancer Therapeutics Biotherapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing investments in research and development of biotherapeutics |
4.2.3 Technological advancements in cancer therapeutics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of biotherapeutics |
4.3.2 High costs associated with cancer treatment |
4.3.3 Limited availability of skilled healthcare professionals specializing in biotherapeutics |
5 Israel Cancer Therapeutics Biotherapeutics Market Trends |
6 Israel Cancer Therapeutics Biotherapeutics Market, By Types |
6.1 Israel Cancer Therapeutics Biotherapeutics Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume, By Therapy Type, 2021 - 2031F |
6.1.3 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume, By Oncolytic Viruses, 2021 - 2031F |
6.1.4 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.2 Israel Cancer Therapeutics Biotherapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.2.3 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3 Israel Cancer Therapeutics Biotherapeutics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.4 Israel Cancer Therapeutics Biotherapeutics Market, By Mechanism |
6.4.1 Overview and Analysis |
6.4.2 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume, By Tumor Lysis, 2021 - 2031F |
6.4.3 Israel Cancer Therapeutics Biotherapeutics Market Revenues & Volume, By Gene Editing, 2021 - 2031F |
7 Israel Cancer Therapeutics Biotherapeutics Market Import-Export Trade Statistics |
7.1 Israel Cancer Therapeutics Biotherapeutics Market Export to Major Countries |
7.2 Israel Cancer Therapeutics Biotherapeutics Market Imports from Major Countries |
8 Israel Cancer Therapeutics Biotherapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for cancer biotherapeutics in Israel |
8.2 Rate of adoption of innovative cancer therapeutics in the market |
8.3 Investment trends in cancer therapeutics research and development |
9 Israel Cancer Therapeutics Biotherapeutics Market - Opportunity Assessment |
9.1 Israel Cancer Therapeutics Biotherapeutics Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 Israel Cancer Therapeutics Biotherapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Cancer Therapeutics Biotherapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Israel Cancer Therapeutics Biotherapeutics Market Opportunity Assessment, By Mechanism, 2021 & 2031F |
10 Israel Cancer Therapeutics Biotherapeutics Market - Competitive Landscape |
10.1 Israel Cancer Therapeutics Biotherapeutics Market Revenue Share, By Companies, 2024 |
10.2 Israel Cancer Therapeutics Biotherapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here